Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-06-03 13:49:31 UTC |
---|
Update Date | 2016-11-09 01:23:26 UTC |
---|
Accession Number | CHEM045929 |
---|
Identification |
---|
Common Name | Clozapine, Desmethyl |
---|
Class | Small Molecule |
---|
Description | A dibenzodoazepine substituted with chloro and piperazino groups which is a major metabolite of clozapine; a potent and selective 5-HT2C serotonin receptor antagonist. |
---|
Contaminant Sources | - HMDB Contaminants - Urine
- STOFF IDENT Compounds
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
8-Chloro-11-(1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine | ChEBI | Demethylclozapine | ChEBI | Desmethylclozapine | ChEBI | N-Desmethyl clozapine | ChEBI | NDMC | ChEBI | 8-Chloro-11-piperazin-1-yl-5H-dibenzo(b,e)(1,4)diazepine | MeSH | Norclozapine | ChEBI |
|
---|
Chemical Formula | C17H17ClN4 |
---|
Average Molecular Mass | 312.797 g/mol |
---|
Monoisotopic Mass | 312.114 g/mol |
---|
CAS Registry Number | 6104-71-8 |
---|
IUPAC Name | 6-chloro-10-(piperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene |
---|
Traditional Name | NDMC |
---|
SMILES | ClC1=CC=C2NC3=CC=CC=C3C(=NC2=C1)N1CCNCC1 |
---|
InChI Identifier | InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2 |
---|
InChI Key | JNNOSTQEZICQQP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as dibenzodiazepines. Dibenzodiazepines are compounds containing a dibenzodiazepine moiety, which consists of two benzene connected by diazepine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | Dibenzodiazepines |
---|
Direct Parent | Dibenzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzodiazepine
- 1,4-benzodiazepine
- Aryl chloride
- Aryl halide
- 1,4-diazinane
- Imidolactam
- Piperazine
- Benzenoid
- Amidine
- Carboxylic acid amidine
- Secondary aliphatic amine
- Azacycle
- Organic 1,3-dipolar compound
- Secondary amine
- Propargyl-type 1,3-dipolar organic compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Organopnictogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0016-9080000000-e5a1e856cf588ec3b2c6 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0009000000-7cf412ccc6a185a32893 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0039000000-447fe506f0de08f3a236 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-2290000000-c1c2dd97da1db1b554a6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0009000000-c0fb9c4f98b955f22ee4 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-0019000000-2a2da1946b96480241e4 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9060000000-b9a39c856d2c8566d39b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0009000000-19ee5c40a0267a7c3d31 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0019000000-cb30f19e8d9094be09aa | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01r6-1091000000-16307b800b31dddedd25 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0009000000-36527b79e8e0db55602b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-1009000000-5ddb83e6baa29fcab0a5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-05ai-4192000000-fda9bbc6faa449b756b5 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB0060536 |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Desmethylclozapine |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | 64050 |
---|
PubChem Compound ID | 135409468 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. https://www.ncbi.nlm.nih.gov/pubmed/?term=20156258 | 2. https://www.ncbi.nlm.nih.gov/pubmed/?term=20463634 | 3. https://www.ncbi.nlm.nih.gov/pubmed/?term=21134422 | 4. https://www.ncbi.nlm.nih.gov/pubmed/?term=21658379 | 5. https://www.ncbi.nlm.nih.gov/pubmed/?term=21712711 | 6. https://www.ncbi.nlm.nih.gov/pubmed/?term=21726287 | 7. https://www.ncbi.nlm.nih.gov/pubmed/?term=21835172 | 8. https://www.ncbi.nlm.nih.gov/pubmed/?term=21855612 | 9. https://www.ncbi.nlm.nih.gov/pubmed/?term=21912901 | 10. https://www.ncbi.nlm.nih.gov/pubmed/?term=21917240 | 11. Ekstrom J, Godoy T, Riva A: N-Desmethylclozapine exerts dual and opposite effects on salivary secretion in the rat. Eur J Oral Sci. 2010 Feb;118(1):1-8. doi: 10.1111/j.1600-0722.2009.00696.x. | 12. Couchman L, Morgan PE, Spencer EP, Flanagan RJ: Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007. Ther Drug Monit. 2010 Aug;32(4):438-47. doi: 10.1097/FTD.0b013e3181dad1fb. | 13. Ertugrul A, Ozdemir H, Vural A, Dalkara T, Meltzer HY, Saka E: The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain Res Bull. 2011 Feb 1;84(2):144-50. doi: 10.1016/j.brainresbull.2010.11.014. Epub 2010 Dec 4. | 14. Godoy T, Riva A, Ekstrom J: Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model. Eur J Oral Sci. 2011 Aug;119(4):275-81. doi: 10.1111/j.1600-0722.2011.00832.x. | 15. Heusler P, Bruins Slot L, Tourette A, Tardif S, Cussac D: The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D(2) and serotonin 5-HT(1)A receptors. Eur J Pharmacol. 2011 Nov 1;669(1-3):51-8. doi: 10.1016/j.ejphar.2011.07.031. Epub 2011 Aug 5. | 16. Humbert-Claude M, Davenas E, Gbahou F, Vincent L, Arrang JM: Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology (Berl). 2012 Mar;220(1):225-41. doi: 10.1007/s00213-011-2471-5. Epub 2011 Sep 13. |
|
---|